CytoSorbents Corporation (CTSO): REMOVE-Results ?

Reply Private New

Replies (3) Next 10 Prev Next

Send PM Follow Ignore

Followers	1
Posts	169
Boards Moderated	0
Alias Born	03/15/2017

Aliberto

Re: clints post# 25985

Monday, 03/01/2021 5:11:41 AM

Monday, March 01, 2021 5:11:41 AM

REMOVE-Results ?

- regarding REMOVE results, after this very current publication (publication date Feb.03.2021) from Switzerland, I am absolutely no longer sure

Hemoadsorption during Cardiopulmonary Bypass in Patients with Endocarditis Undergoing Valve Surgery

- ... maybe this is why the publication of the REMOVE results will be "postponed" and the head of studies and CTSO management is now desperately looking for any positive data in the results

COVID-use ?

- can it be used at all for Corona in Germany due to the new "Recommendations (= guidelines !) for inpatient therapy for patients with COVID-19" at the ICU?
(See point 7.1 "Hospitalized patients with COVID-19 should receive standard drug thromboembolism prophylaxis with low molecular weight heparin in the absence of contraindications. Fondaparinux can be used as an alternative.")

S3-guideline - recommendations for inpatient therapy for patients with COVID-19